Histological recovery and gluten-free diet adherence: A prospective 1-year follow-up study of adult patients with coeliac disease

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 6, 2014, Pages 639-647

  Galli, G ^a   Esposito, G ^a   Lahner, E ^a   Pilozzi, E ^a   Corleto, V D ^a,b   Di Giulio, E ^a   Aloe Spiriti, M A ^a   Annibale, B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY COMPLIANCE; FEMALE; FOLLOW UP; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; TISSUE REGENERATION;

ADULT; ATROPHY; BIOPSY; CELIAC DISEASE; DIET, GLUTEN-FREE; DUODENUM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84906248281     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12893     Document Type: Article

References (39)

1. Marsh MN,. Gluten major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992; 102: 330-54.
2. Fasano A, Catassi C,. Clinical practice: celiac disease. N Engl J Med 2012; 367: 2419-26.
3. Oberhuber G, Granditsch G, Volgelsang H,. The histopathology of coeliac disease: time for standardized report scheme for the pathologists. Eur J Gastroenterol Hepatol 1999; 11: 1185-94.
4. Rostom A, Kagnoff MF, Murray JA,. American Gastroenterological association Institute technical review on the diagnosis and management of Celiac disease. Gastroenterology 2006; 131: 1981-2002.
5. Nachman F, Sugai E, Vazquez H, et al,. serological tests for celiac disease as indicators of long-term compliance with the gluten-free diet. Eur J Gastroenterol Hepatol 2011; 23: 473-80.
6. Haines ML, Anderson RP, Gibson PR,. Systematic review: the evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther 2008; 28: 1042-66.
7. Leffler DA, Schuppan D,. Update on serologic testing in celiac disease. Am J Gastroenterol 2010; 105: 2520-4.
8. Rubio-Tapia A, Hill ID, Kelly CP, et al,. ACG Clinical guideline: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108: 656-76.
9. Pietzak MM,. Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology 2005; 128: S135-41.
10. Sharkey LM, Corbett G, Currie E, et al,. Optimising delivery of care in celiac disease- comparison of the benefits of repeat biopsy and serological follow-up. Aliment Pharmacol Ther 2013; 38: 1278-91.
11. Lee SK, Lo W, Memeo L, et al,. Duodenal histology in patients with celiac disease after treatment with gluten-free diet. Gastrointest Endosc 2003; 57: 187-91.
12. Tursi A, Brandimarte G, Giorgetti GM,. Lack of usefulness of anti-transglutaminase antibodies in assessing histologic recovery after gluten-free diet in celiac disease. J Clin Gastroenterol 2003; 37: 387-91.
13. Kaukinen K, Peraaho M, Lindfors K, et al,. Persistent small bowel villous atrophy without symptoms in celiac disease. Aliment Pharmacol Ther 2007; 25: 1237-45.
14. Murray JA, Watson T, Clearman B, et al,. Effect of gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004; 79: 669-73.
15. Ludvigsson JF, Bai JC, Biagi F, et al,. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 2014; 63: 1210-28.
16. Lanzini A, Lanzarotto F, Villanacci V, et al,. Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet. Aliment Pharmacol Ther 2009; 29: 1299-308.
17. Lebwohl B, Granath F, Ekbom A, et al,. Mucosal healing and mortality in coeliac disease. Aliment Pharmacol Ther 2013; 37: 332-9.
18. Collin P, Maki M, Kaukinen K,. Complete small intestinal mucosal recovery is obtainable in the treatment of celiac disease. Gastrointest Endosc 2004; 59: 158-60.
19. Bardella MT, Velio P, Cesana BM, et al,. Coeliac disease: a histological follow-up study. Histopathology 2007; 50: 465-71.
20. Wahab PJ, Meijer JWR, Mulder CJJ,. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Pathol 2002; 118: 459-63.
21. Tursi A, Brandimarte G, Giorgetti GM, et al,. Endoscopic and histological findings in the duodenum of adults with celiac disease before and after changing to a gluten-free diet. Endoscopy 2006; 38: 702-7.
22. Dickey W, Hughes DF, Path FRC, et al,. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol 2000; 95: 712-4.
23. Biagi F, Andrealli A, Bianchi PI, et al,. A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease. Br J Nutr 2009; 102: 882-7.
24. Biagi F, Bianchi PI, Marchese A, et al,. A score that verifies adherence to a gluten-free diet: a cross-sectional, multicentre validation in real clinical life. Br J Nutr 2012; 108: 1884-8.
25. Ciacci C, Cirillo M, Cavallaro R, et al,. Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage. Digestion 2002; 66: 178-85.
26. Rubio-Tapia A, Rahim MW, See JA, et al,. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2009; 105: 1412-20.
27. Kaukinen K, Sulkanen S, Maki M, et al,. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol 2002; 14: 311-5.
28. Vahedi K, Mascart F, Mary JY, et al,. Reliability of Antitransglutaminase antibodies as predictors of Gluten free diet compliance in adult celiac disease. Gastroenterology 2000; 121: A3819.
29. Hogberg L, Grodzinsky E, Stenhammar L,. Better dietary compliance in patients with coeliac disease diagnosed in early childhood. Scand J Gastroenterol 2003; 38: 751-4.
30. Bardella MT, Molteni N, Prampolini L, et al,. Need for follow-up in coeliac disease. Arch Dis Child 1994; 70: 211-3.
31. Grefte JMM, Bouman JG, Grond J, et al,. Slow and incomplete histological and functional recovery in adult gluten sensitive enteropathy. J Clin Pathol 1988; 41: 886-91.
32. Lebwohl B, Murray JA, Rubio-Tapia A, et al,. Predictors of persistent villous atrophy in coeliac disease: a population-based study. Aliment Pharmacol Ther 2014; 39: 488-95.
33. VandeVoort JL, Murray JA, Lahr BD, et al,. Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol 2009; 104: 142-8.
34. Kakar S, Nehra V, Murray JA, et al,. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol 2003; 98: 2027-33.
35. Tuire I, Lähdeaho ML, Salmi T, et al,. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease. Am J Gastroenterol 2012; 107: 1563-9.
36. Fine KD, Meyer RL, Lee EL, et al,. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997; 114: 424-5.
37. Bardella MT, Molteni N, Quatrini M, et al,. Clinical biochemical and histological abnormalities in adult celiac patients on gluten-free diet. Gastroenterol Clin Biol 1985; 9: 787-9.
38. Capristo E, Malandrino N, Farnetti S, et al,. Increased serum High-density lipoprotein-cholesterol concentration in celiac disease after Gluten-free diet treatment correlates with body fat stores. J Clin Gastroenterol 2009; 43: 946-9.
39. Lebwohl B, Granth F, Ekbom A, et al,. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med 2013; 159: 169-75.